We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 28.00 | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/2/2019 15:47 | I thought it was being ramped but after due diligence and thorough research I see the potential here as does everyone else. 1p will never be seen again | letmepass | |
20/2/2019 15:41 | LetmepassPlease explain post 619?I am confused as you said wait a few days for 1p??Am I mistaken?? | glenbo1 | |
20/2/2019 15:36 | This is big big news | letmepass | |
20/2/2019 15:34 | They placed in December and if they need to place again I think that it would be a lot higher than 1p.Why are you saying a placing??? | glenbo1 | |
20/2/2019 15:33 | This is just the start. So much more to come. Will be multiples higher by end of year imo. "This is the first of several announcements expected over the coming weeks and months as hemp-derived CBD inclusive formulation tests extend to Labskin model systems that have disease state bacteria such as seen in acne and eczema. As well as having an extension to the range of STOER For Men skin care products, Labskin will be offering the same test services to clients adding CBD to their skin-care and cosmetic range of products." | someuwin | |
20/2/2019 15:31 | will be a few days of good rises before a placing. | datait | |
20/2/2019 15:29 | Watch for a placing of £2m at 1p | bigboots | |
20/2/2019 15:28 | There is very little scientific research evidence of the value of CBD. This looks like actual proof that it works. This puts Labskin in a unique position of being one, if not the only one, who can offer services that validate CBD producers and skin care companies, that their products actually work. | mulligut | |
20/2/2019 15:28 | They are not sells | glenbo1 | |
20/2/2019 15:27 | Why all the sells | herb clark | |
20/2/2019 15:15 | Is this patented or can anybody produce this skunk based product? | katsy | |
20/2/2019 15:02 | As I said earlier 4p will only be a valuation of £18m Which seems cheap when you look at their diverse portfolio of technologies, products and services. | someuwin | |
20/2/2019 15:00 | No one wants to sell wonder why lol | datait | |
20/2/2019 14:39 | HOw stupid is this window licker? What dividend? Moron!! DATAIT20 Feb '19 - 12:49 - 621 of 646 0 0 0 Dont buy for the divi as it will fall on the day anyway | elcapital2018 | |
20/2/2019 14:37 | CEO owns 10.8% and COO/CFO owns 9.1%. Plenty of SKIN in the game! | someuwin | |
20/2/2019 14:37 | not enough stock this will go through the roof. | datait | |
20/2/2019 14:33 | last half hour and a early morning could touch 2p | sigora | |
20/2/2019 14:28 | There will be a few days of rising before a placing happens. | datait |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions